{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:29:23Z","timestamp":1774085363197,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[1995,10]]},"DOI":"10.1007\/bf01052845","type":"journal-article","created":{"date-parts":[[2005,1,27]],"date-time":"2005-01-27T11:29:06Z","timestamp":1106825346000},"page":"285-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Attempted dose intensified cyclophosphamide, etoposide, and granulocyte colony-stimulating factor for treatment of malignant astrocytoma"],"prefix":"10.1007","volume":"24","author":[{"given":"Herbert B.","family":"Newton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl L.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01052845_CR1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3171\/jns.1978.49.3.0333","volume":"49","author":"M Walker","year":"1978","unstructured":"Walker M, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Norrell HA, Owens G, Ransahoff J, Wilson CB, Gehan EA, Strike TA: Evaluation of BCNU and\/or radiotherapy in the treatment of anaplastic glioma. J Neurosurg 49: 333\u2013343, 1978","journal-title":"J Neurosurg"},{"key":"BF01052845_CR2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","volume":"303","author":"M Walker","year":"1980","unstructured":"Walker M, Green SB, Byar DP, Alexander E, Batzdorf FU, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Owens G, Ransahoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323\u20131329, 1980","journal-title":"N Engl J Med"},{"key":"BF01052845_CR3","first-page":"121","volume":"67","author":"SB Green","year":"1983","unstructured":"Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E, Batzdorf U, Brooks WH, Hunt WE, Mealey J, Odom GL, Paoletti P, Ransohoff J, Robertson JT, Selker RG, Shapiro WR, Smith KR, Wilson CB, Strike TA: Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67: 121\u2013132, 1983","journal-title":"Cancer Treat Rep"},{"key":"BF01052845_CR4","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.40.11.1743","volume":"40","author":"HB Newton","year":"1990","unstructured":"Newton HB, Page MA, Junck L, Bromberg J, Greenberg HS: Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure. Neurology 40: 1743\u20131746, 1990","journal-title":"Neurology"},{"key":"BF01052845_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01050072","volume":"15","author":"HB Newton","year":"1993","unstructured":"Newton HB, Bromberg J, Junck L, Page MA, Greenberg HS: Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas. J Neuro-Oncol 15: 257\u2013263, 1993","journal-title":"J Neuro-Oncol"},{"key":"BF01052845_CR6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0360-3016(90)90096-3","volume":"18","author":"VA Levin","year":"1990","unstructured":"Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Rad Oncol Biol Phys 18: 321\u2013324, 1990","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"BF01052845_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.1988.68.1.0001","volume":"68","author":"PL Kornblith","year":"1988","unstructured":"Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68: 1\u201317, 1988","journal-title":"J Neurosurg"},{"key":"BF01052845_CR8","first-page":"93","volume":"7","author":"AP Kyritsis","year":"1993","unstructured":"Kyritsis AP: Chemotherapy for malignant gliomas. Oncology 7: 93\u2013100, 1993","journal-title":"Oncology"},{"key":"BF01052845_CR9","first-page":"65","volume":"14","author":"WM Hryniuk","year":"1987","unstructured":"Hryniuk WM: Average relative dose intensity and the impact on design of clinical trials. Semin Oncol 14: 65\u201374, 1987","journal-title":"Semin Oncol"},{"key":"BF01052845_CR10","first-page":"121","volume-title":"Important Advances in Oncology 1988","author":"WM Hyrniuk","year":"1988","unstructured":"Hyrniuk WM: The importance of dose intensity in the outcome of chemotherapy. In: De Vita VT, Hellman S, Rosenberg SA (eds) Important Advances in Oncology 1988. J.B. Lippincott, Philadelphia, pp 121\u2013142, 1988"},{"key":"BF01052845_CR11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.1984.2.11.1281","volume":"2","author":"W Hryniuk","year":"1984","unstructured":"Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2: 1281\u20131288, 1984","journal-title":"J Clin Oncol"},{"key":"BF01052845_CR12","first-page":"67","volume":"7","author":"LL Miller","year":"1993","unstructured":"Miller LL: Current status of G-CSF in support of chemotherapy and radiotherapy. Oncology 7: 67\u201383, 1993","journal-title":"Oncology"},{"key":"BF01052845_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/bjc.1989.234","volume":"60","author":"MH Bronchud","year":"1989","unstructured":"Bronchud MH, Howell A, Crowther D, Hopwood P, Souza L, Dexter TM: The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer 60: 121\u2013125, 1989","journal-title":"Br J Cancer"},{"key":"BF01052845_CR14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199107183250305","volume":"325","author":"J Crawford","year":"1991","unstructured":"Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Giaspy J: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325: 164\u2013170, 1991","journal-title":"N Engl J Med"},{"key":"BF01052845_CR15","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJM198806023182202","volume":"318","author":"JL Gabrilove","year":"1988","unstructured":"Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welte K, Souza L: Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318: 1414\u20131422, 1988","journal-title":"N Engl J Med"},{"key":"BF01052845_CR16","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/1097-0142(19901101)66:9<1904::AID-CNCR2820660908>3.0.CO;2-V","volume":"66","author":"T Yoshida","year":"1990","unstructured":"Yoshida T, Nakamura S, Ohtake S, Okafuji K, Kobayashi K, Kondo K, Kanno M, Matano S, Matsuda T, Kanai M, Sugimoto R, Ogawa M, Takaku F: Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma. Cancer 66: 1904\u20131909, 1990","journal-title":"Cancer"},{"key":"BF01052845_CR17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3171\/jns.1981.55.5.0749","volume":"55","author":"JC Allen","year":"1981","unstructured":"Allen JC, Helson L: High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55:749\u2013756, 1981","journal-title":"J Neurosurg"},{"key":"BF01052845_CR18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3171\/jns.1990.72.4.0583","volume":"72","author":"DC Longee","year":"1990","unstructured":"Longee DC, Friedman HS, Albright RE, Burger PC, Oakes WJ, Moore JO, Schold SC: Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine. J Neurosurg 72: 583\u2013588, 1990","journal-title":"J Neurosurg"},{"key":"BF01052845_CR19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00177840","volume":"8","author":"RM Hellman","year":"1990","unstructured":"Hellman RM, Calogero JA, Kaplan BM: VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors. J Neuro-Oncol 8: 163\u2013166, 1990","journal-title":"J Neuro-Oncol"},{"key":"BF01052845_CR20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1200\/JCO.1984.2.5.432","volume":"2","author":"U Tirelli","year":"1984","unstructured":"Tirelli U, D'Incali M, Canetta R, Tumolo S, Franchin G, Veronesi A, Galligioni E, Trovo MG, Rossi C, Grigolitto E: Etoposide (VP-16-213) in malignant brain tumors: A phase II study. J Clin Oncol 2: 432\u2013437, 1984","journal-title":"J Clin Oncol"},{"key":"BF01052845_CR21","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T","volume":"62","author":"C Daumas-Duport","year":"1988","unstructured":"Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P: Grading of astrocytomas: a simple and reproducible method. Cancer 62: 2152\u20132165, 1988","journal-title":"Cancer"},{"key":"BF01052845_CR22","unstructured":"National Cancer Institute: Common Toxicity Criteria. Bethesda, MD, NCI, 1988"},{"key":"BF01052845_CR23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.165.4.941","volume":"165","author":"K Welte","year":"1987","unstructured":"Welte K, Bonilla MA, Gillio AP, Boone TC, Potter GK, Gabrilove JL, Moore MAS, O'Reilly RJ, Souza LM: Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 165: 941\u2013948, 1987","journal-title":"J Exp Med"},{"key":"BF01052845_CR24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/bjc.1987.295","volume":"56","author":"MH Bronchud","year":"1987","unstructured":"Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM: Phase I\/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56: 809\u2013813, 1987","journal-title":"Br J Cancer"},{"key":"BF01052845_CR25","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.1989.7.11.1685","volume":"7","author":"J Neidhart","year":"1989","unstructured":"Neidhart J, Mangalik A, Kohler W, Stidley C, Saiki J, Duncan P, Souza L, Downing M: Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation. J Clin Oncol 7: 1685\u20131692, 1989","journal-title":"J Clin Oncol"},{"key":"BF01052845_CR26","first-page":"849","volume":"71","author":"SC Schold","year":"1987","unstructured":"Schold SC, Friedman HS, Bigner DD: Therapeutic profile of the human glioma line D-54 MG in athymic mice. Cancer Treat Rep 71: 849\u2013850, 1987","journal-title":"Cancer Treat Rep"},{"key":"BF01052845_CR27","first-page":"84","volume":"8","author":"J Miser","year":"1989","unstructured":"Miser J, Krailo M, Smithson W, Belasco J, Ortega J, Hammond GD: Treatment of children with recurrent brain tumors with ifosfamide (IFOS), etoposide (VP16) and MESNA (M). Results of a phase II trial (abstract). Proceed ASCO 8: 84, 1989","journal-title":"Proceed ASCO"},{"key":"BF01052845_CR28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.1980.03310020055033","volume":"244","author":"PH Wiernick","year":"1980","unstructured":"Wiernick PH: The management of infections in the cancer patient. J Am Med Assoc 244: 185\u2013187, 1980","journal-title":"J Am Med Assoc"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01052845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF01052845\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01052845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01052845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T21:45:50Z","timestamp":1659044750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF01052845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["BF01052845"],"URL":"https:\/\/doi.org\/10.1007\/bf01052845","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,10]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}